Medicared For All Logo

Enrique Diaz Guzman Zavala in Pensacola, Florida

Home Florida Pensacola

Enrique Diaz Guzman Zavala has Pulmonary Disease as his primary medical specialty. Their primary office is: 4700 Bayou Blvd in Pensacola, Florida.

They're a part of the: Pensacola Lung Group, M.d.'s, P.a. medical group which has around 9 members. You can call their office at 850-477-9253 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1997 (around 27 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Enrique Diaz Guzman Zavala Office Phone and Directions

Enrique Diaz Guzman Zavala
Pensacola Lung Group, M.d.'s, P.a.
4700 Bayou Blvd
Pensacola, Florida 32503
850-477-9253


Patient Ratings
Please rate your experience with Enrique Diaz Guzman Zavala below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 850-477-9253


Enter a starting address:


Healthcare Info for Enrique Diaz Guzman Zavala

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: Sorry, his university is not listed
Graduation Year: 1997
The Primary Medical Specialty for Enrique Diaz Guzman Zavala is listed as: Pulmonary Disease
Approximate Years of Experience: 27
PAC (PECOS ID)#: 9234281106
NPI #: 1326229733
NPI Created On: 11/14/2007
NPI Last Updated Listed as: 06/18/2016
Primary Taxonomy Code: 207RP1001X
License Number:
57.007160
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Irrigation and suction of lung airways to obtain cells using an endoscope
  2. Measurement and graphic recording of total and timed exhaled air capacity
  3. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  4. Test for exercise-induced lung stress
  5. Determination of lung volumes using plethysmography
  6. Measurement of lung diffusing capacity
  7. New patient office or other outpatient visit, typically 45 minutes
  8. New patient office or other outpatient visit, typically 60 minutes
  9. Established patient office or other outpatient visit, typically 15 minutes
  10. Established patient office or other outpatient, visit typically 25 minutes
  11. Established patient office or other outpatient, visit typically 40 minutes
  12. Initial hospital inpatient care, typically 70 minutes per day
  13. Subsequent hospital inpatient care, typically 25 minutes per day
  14. Subsequent hospital inpatient care, typically 35 minutes per day
  15. Critical care delivery critically ill or injured patient, first 30-74 minutes
  16. Critical care delivery critically ill or injured patient

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788117649

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788117651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788117653

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788117647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801984753

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802051489

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802123877

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802203927

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802489879

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802725413

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Pulmonary Disease Professionals in Pensacola

435 Airport Blvd
Pensacola, FL
Pulmonary Critical Care And Sleep Disorders Medicine Pa

4700 Bayou Blvd
Pensacola, FL
Pensacola Lung Group, M.d.'s, P.a.

4700 Bayou Blvd
Pensacola, FL
Pensacola Lung Group, M.d.'s, P.a.

1000 W Moreno St
Pensacola, FL

5151 N 9th Ave
Pensacola, FL

4700 Bayou Blvd
Pensacola, FL
Pensacola Lung Group, M.d.'s, P.a.

Providers in Pensacola Lung Group, M.d.'s, P.a.

1.Peter Bercz

4700 Bayou Blvd
Pensacola Fl 32503-1901
Pensacola Lung Group, M.d.'s, P.a.
Pulmonary Disease

2.John Bray

4700 Bayou Blvd
Pensacola Fl 32503-1901
Pensacola Lung Group, M.d.'s, P.a.
Pulmonary Disease

3.Enrique Diaz Guzman Zavala

4700 Bayou Blvd
Pensacola Fl 32503-1901
Pensacola Lung Group, M.d.'s, P.a.
Pulmonary Disease

4.Peter Marco

4700 Bayou Blvd
Pensacola Fl 32503-1901
Pensacola Lung Group, M.d.'s, P.a.
Pulmonary Disease

5.Frank Messina

4700 Bayou Blvd
Pensacola Fl 32503-1901
Pensacola Lung Group, M.d.'s, P.a.
Pulmonary Disease

6.Luis Murillo

4700 Bayou Blvd
Pensacola Fl 32503-1901
Pensacola Lung Group, M.d.'s, P.a.
Pulmonary Disease

View all 9 members of Pensacola Lung Group, M.d.'s, P.a. medical group